Enhanced thromboprophylaxis in critically ill patients with COVID-19 infection
Background: Patients with severe SARS-CoV-2 infection have been shown to have abnormal coagulation parameters and are at increased risk of thromboembolism. The optimal thromboprophylaxis regimen that minimizes thrombosis without increased risk of serious bleeding is uncertain. Objectives: To describ...
Main Authors: | R.L. Kummer, K.A. Considine, M.A. Rankin, L.M. Hubbard, T.S. Lam, L.T. Thornton, A.R. Lindsay, A.S. Ahiskali, J.W. Leatherman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-05-01
|
Series: | Thrombosis Update |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666572721000171 |
Similar Items
-
New Paradigms of Extended Thromboprophylaxis in Medically Ill Patients
by: Kira MacDougall, et al.
Published: (2020-04-01) -
Identification and Outcomes of Hospitalized Medically Ill Patients Who Are Candidates for Extended Duration Thromboprophylaxis
by: Craig I. Coleman, et al.
Published: (2020-10-01) -
What Do We Know about Thromboprophylaxis and Its Monitoring in Critically Ill Patients?
by: Philippe Cauchie, et al.
Published: (2021-07-01) -
Direct oral anticoagulants for extended thromboprophylaxis in medically ill patients: meta-analysis and risk/benefit assessment
by: Al Yami MS, et al.
Published: (2018-02-01) -
Primary Thromboprophylaxis in Ambulatory Cancer Patients: Where Do We Stand?
by: Frits I. Mulder, et al.
Published: (2020-02-01)